Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Viral safety issues: plasma-derived factor VIII.

× No keyword cloud information.

14 in total

1. Transmission of hepatitis C with pasteurised factor VIII.

Authors: S Schulman; A C Lindgren; P Petrini; T Allander
Journal: Lancet Date: 1992-08-01 Impact factor: 79.321

2. Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. The Study Group of the Fondazione dell'Emofilia.

Authors: P M Mannucci; A R Zanetti; M Colombo; A Chistolini; R De Biasi; R Musso; G Tamponi
Journal: Thromb Haemost Date: 1990-10-22 Impact factor: 5.249

3. Survey of non-U.S. hemophilia treatment centers for HIV seroconversions following therapy with heat-treated factor concentrates.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 1987-03-13 Impact factor: 17.586

4. Acute hepatitis B infection after treatment with heat-inactivated factor VIII concentrate.

Authors: H H Brackmann; H Egli
Journal: Lancet Date: 1988-10-22 Impact factor: 79.321

5. If nothing goes wrong, is everything all right? Interpreting zero numerators.

Authors: J A Hanley; A Lippman-Hand
Journal: JAMA Date: 1983-04-01 Impact factor: 56.272

6. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions.

Authors: K Schimpf; P M Mannucci; W Kreutz; H H Brackmann; G Auerswald; N Ciavarella; J Mösseler; V DeRosa; B Kraus; C Brueckmann
Journal: N Engl J Med Date: 1987-04-09 Impact factor: 91.245

7. Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate.

Authors: M Colombo; P M Mannucci; V Carnelli; G F Savidge; C Gazengel; K Schimpf
Journal: Lancet Date: 1985-07-06 Impact factor: 79.321

8. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin.

Authors: P B Kernoff; C A Lee; P Karayiannis; H C Thomas
Journal: Br J Haematol Date: 1985-07 Impact factor: 6.998

9. Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group.

Authors: P M Mannucci; K Schimpf; T Abe; L M Aledort; K Anderle; D B Brettler; M W Hilgartner; P B Kernoff; M Kunschak; C W McMillan
Journal: Transfusion Date: 1992-02 Impact factor: 3.157

10. Viral safety and inhibitor development associated with factor VIIIC ultra-purified from plasma in hemophiliacs previously unexposed to factor VIIIC concentrates. The Monoclate Study Group.

Authors: J M Lusher; P M Salzman
Journal: Semin Hematol Date: 1990-04 Impact factor: 3.851